The effects of ISL on prostate cancer cell line DU145 have been investigated, finding that cell cycle arrest in the G2M phase decreases CDC25C and increases p-CDC2 (Tyr15), cyclin B1, and p27KIP1 [115]. This evidence concerns the gene CDK1 and prostate carcinoma.